279683
Diagnostic implications of craving in assessing disorders for commonly-abused substances
Methods. Raters content analyzed the abstracts to identify relevant articles by disorder (reliability was established on 10 abstracts). Relevant articles were fully content analyzed. Articles were extracted for diagnosis criteria and conclusions related to diagnosis and craving for each disorder separately.
Results. A study flow diagram (number of abstracts reviewed, number articles fully reviewed) by substance. A series of mini-reviews indicated global and local criteria regarding the utility of craving in the diagnosis for each substance use disorder, separately. Conclusions. Findings suggest that historical and contemporary developments in global diagnostic criteria can ultimately affect local mental health practice. Implications for local mental health practice are discussed.
Provision of health care to the public
Public health or related laws, regulations, standards, or guidelines
Public health or related organizational policy, standards, or other guidelines
Public health or related research
Learning Objectives:
Describe the gap between global (ICD) and local (DSM) criteria for substance use disorders (SUD).
Identify the role of craving in predicting common SUDs.
Explain how historical through recent developments in global diagnostic criteria can ultimately affect local mental health practice.
Keywords: Substance Abuse Assessment, Substance Abuse Treatment
Qualified on the content I am responsible for because: I am senior research scientist at MayaTech and expert consultant for the National Institute on Drug Abuse (NIDA) Intramural Research Program (IRP). I previously headed a NIDA IRP lab that investigated the relationship between drug use and craving. I am a fellow of the College on Problems of Drug Dependence and former member of the American Psychological Association’s Expert Working Group on the Treatment of Alcohol and Other Psychoactive Substance Abuse.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.